GYNEVIA, THE CLINICALLY PROVEN SOLUTION

The efficacy of Gynevia on bacterial vaginosis has been proven in 2 clinical studies including 78 women.

Post antibiotic treatment (N=42)

clinical study

key point100% of women treated with Gynevia have retrieved a healthy vaginal flora (Nugent Score ≤ 3) after 8 days of treatment while no evolution is measured in the lactic acid group.

key pointBacterial vaginosis recurrence is reduced by 42% with the use of Gynevia after antibiotic therapy.

Preventive treatment (N=36)

Inclusion criteria: Women with a mean of 3 bacterial vaginosis per year

clinical study

key point80.5% of women have not faced bacterial vaginosis relapses within the 6 months following the end of the treatment.

key pointGynevia's preventive use durably restores vaginal balance, and thus stops bacterial vaginosis relapses.

The method of Nugent is a microscopic examination of vaginal secretions. The presence and amounts of 3 bacterial morphotypes (Lactobacilli, Gardnerella vaginalis, Mobiluncus species) are assessed to diagnose a bacterial vaginosis. The Nugent score is classified as follows: 0-3 is considered negative for bacterial vaginosis (BV) / 4-6 is considered intermediate / 7+ is considered indicative of BV.